New Alzheimer’s drug 

(many questions remain and many uncertainties lie ahead)

Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.
DONATE NOW

     
Imagine knowing someone for an entire lifetime who cannot place your face or remember your name. For Mary Kobiernicki, freshman in Business, the feeling is all too familiar. Kobiernicki’s grandfather passed away two years ago to Alzheimer’s disease — but with the identification of a new potential drug target for treatment of the deadly disease made by two University professors, perhaps a better future is possible.
Dr. Kevin Xiang and Dr. Charles Cox, molecular and integrative physiology professors at the University, recently discovered a new possible piece for solving the elusive Alzheimer’s puzzle. Alzheimer’s is a complex disease, and to understand it is to dissect it, explained Xiang. To better explain what has been uncovered by these two professors, Xiang took to the drawing board. Allowing Cox to sketch the brain, Xiang mapped out that Alzheimer’s begins with the formation of plaque in the brain. This plaque “is the hallmark of the disease,” Cox said. Though no one can be completely certain a patient has Alzheimer’s unless peering inside the patient’s brain to discover such plaque, the idea behind their research is to make this connection sooner, before death, Cox said. Such plaque, made up of a protein fragment called amyloid-beta is where the Alzheimer’s puzzle begins to be deciphered, for it is the substance causing the most damage, Xiang said. Read more: dailyillini.com

TODAY'S PHOTO

 

Resveratrol may boost blood flow in the brain

High doses of resveratrol may improve blood flow in the brain and potentially boost brain health, say results of a new human study from the UK.   Read more: nutraingredients.com

Беларусь ТВ

Posted YVN (AMYLOID @ PHOTO)